Sugisaka J, Fujimoto D, Tamiya M, Hata A, et al. Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study. Lung Cancer 2024;199:108056.
PMID: 39674045